Mental, Behavioral and Development Health

Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights the April, 2025, issue of Contemporary Pediatrics, with a special focus on pediatric allergy awareness.

A newly published Swedish study supports other research that suggests screen time displaces sleep in multiple ways.

View our Q1 2025 recap of standout pediatric news from FDA regulatory updates, clinical trial results, and expert commentary.

Research suggests that sex-based differences in the kynurenine pathway may contribute to depression risk in adolescents.

13-year-old female with altered mental status, headache and emesis. What is the diagnosis?

Can you diagnose this patient? Take our poll and find out! Then check back for the full case, differential diagnosis, and correct diagnosis.

Discover mental health screening tools for the pediatric primary care provider.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

With 1 in 7 adolescents worldwide diagnosed with mental health disorders, emerging research suggests that diet is a powerful yet often overlooked therapeutic tool.

Peter S. Jensen, MD, discusses the risks and benefits of social media use by children, emphasizing the need for parental oversight and national guidelines.

Pediatricians face rising demands in specialty care and mental health, with programs such as REACH helping them manage these challenges.

Early anxiety screening in pediatric primary care improves detection, outcomes, and access to mental health support starting at age 8.

Mike Hennessy Jr, President and CEO of MJH Life Sciences kicks off our March Mental Health issue with a look into the ongoing pediatric mental health crisis.

Results will be included an a final analysis of safety and efficacy data for CTx-1301, which will be included in a NDA submission with the FDA, stated Cingulate Inc.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

Higher physical activity and lower screen time in childhood were linked to reduced stress and depression in adolescence, according to a Finnish cohort study.

Peter S. Jensen, MD, comments on the challenges primary health care providers may face when it comes to mental health treatment in pediatrics, and provides screening tools to consider to combat these challenges.

"My takeaway is that if medicine is needed, stimulants will be my first choice in this age group, regardless of whether the ADHD coexists with ASD."

Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights the January/February, 2025, issue of Contemporary Pediatrics.

"In aggregation with other robust observational studies, these results can inform the management of asthma and allergic rhinitis in this patient group," wrote the study authors.

Recent research evaluated the association between screen time and autism spectrum disorder by considering socioeconomic factors as instrumental variables.

Prenatal exposure to antiseizure medications like valproate and topiramate raises risks of ASD, ADHD, and ID in children; lamotrigine shows no increased risk.

Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights the final Contemporary Pediatrics journal of the year.

Lifestyle medicine and mental health management in pediatric primary care promote positive health and holistic well-being.

A discussion of tips and recommendations general providers can use when evaluating ADHD in pediatric patients.

At any point in the study, adolescents who used cannabis reported a greater number of psychosis spectrum symptoms.

Rakesh Jain, MD, MPH, notes that with increasing ADHD trends, a newly-available and FDA-approved non-stimulant tool can help treat more patients.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from last week, all in one place.

Jain breaks down key benefits of clonidine hydrochloride (ONYDA XR; Tris Pharma) to treat ADHD among patients aged 6 years and older.

The detected reduction in HRs for suicidal ideation among adolescents with obesity prescribed GLP1R suggests potential avenues for future research.